{"entity":{"id":"d9db48b5-50cc-5ca3-bd47-e60c063bda49","name":"LIU VIVIAN H","type":"Company","kind":"company","jurisdiction":"US","identifier":"sec:0001203467","risk":"LOW","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"as_observed":"Edges carry the date we OBSERVED them in a source registry, not a validity period. We do not currently hold ownership end dates, so a link shown here may have ended. Check the source record before relying on currency.","direct_owners":[],"holdings":[{"role":"officer","share":null,"source":"SEC EDGAR","subsidiary":{"id":"e7763fb4-4afc-5a47-a077-fda08793cb68","name":"APRICUS BIOSCIENCES, INC.","type":"Company","kind":"company","identifier":"sec:0001017491"}},{"role":"director","share":null,"source":"SEC EDGAR","subsidiary":{"id":"6520f7a2-4c3d-549e-b238-3c4e7551f25e","name":"AYTU BIOPHARMA, INC","type":"Company","kind":"company","identifier":"sec:0001385818"}},{"role":"director","share":null,"source":"SEC EDGAR","subsidiary":{"id":"4a24b362-8ae0-5e72-a2ae-cf8211e6eddb","name":"CESCA THERAPEUTICS INC.","type":"Company","kind":"company","identifier":"sec:0000811212"}},{"role":"director","share":null,"source":"SEC EDGAR","subsidiary":{"id":"dd12304d-86aa-525e-abde-ebc3028d9f4b","name":"INNOVUS PHARMACEUTICALS, INC.","type":"Company","kind":"company","identifier":"sec:0001411879"}},{"role":"officer","share":null,"source":"SEC EDGAR","subsidiary":{"id":"4a24b362-8ae0-5e72-a2ae-cf8211e6eddb","name":"CESCA THERAPEUTICS INC.","type":"Company","kind":"company","identifier":"sec:0000811212"}},{"role":"officer","share":null,"source":"SEC EDGAR","subsidiary":{"id":"dd12304d-86aa-525e-abde-ebc3028d9f4b","name":"INNOVUS PHARMACEUTICALS, INC.","type":"Company","kind":"company","identifier":"sec:0001411879"}},{"role":"director","share":null,"source":"SEC EDGAR","subsidiary":{"id":"e7763fb4-4afc-5a47-a077-fda08793cb68","name":"APRICUS BIOSCIENCES, INC.","type":"Company","kind":"company","identifier":"sec:0001017491"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (aircraft/sanctioned vessels/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing.","mcp":{"install":"npx -y @whiteintel/mcp-server","tools":["get_dossier","trace_ownership_path","check_offshore_exposure"],"note":"Call this dossier as a tool from your agent; buy in-flow with get_pricing/buy_dossier/get_payment_link."}},"source":"corpus"}